CoChat

Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment

Open access
Riedel, Wim J., Eikmans, Karin, Heldens, Annet, Schmitt, Jeroen A. J. · 2005 · Journal of Psychopharmacology
Cited by 73

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Subchronic treatment with the selective serotonergic reuptake inhibitors (SSRIs) fluoxetine, venlafaxine and paroxetine, but not sertraline, were previously shown to specifically impair vigilance performance. The current study was designed to compare the vigilance effects of subchronic treatment with the SSRIs sertraline and citalopram in healthy volunteers, according to a placebo-controlled, double-blind, three-way cross-over design. Twenty-four healthy subjects, aged 30-50 years, of whom 21 completed the study, underwent three treatment periods of 2 weeks in which they received sertraline (50 mg on days 1-8, 100 mg on days 8-15), citalopram (20 mg on days 1-8, 40 mg on days 8-15) and placebo. Treatment periods were separated by 14 days washout periods. Vigilance performance was assessed through a 45-min Mackworth Clock Test at days 1, 8 and 15 of each treatment period. It was found that citalopram impaired vigilance performance acutely after the first 20 mg dose and subchronically after 40 mg daily doses. By contrast, no vigilance impairment was found during sertraline treatment. Sertraline is the only SSRI studied so far with no detrimental effects on vigilance. This may be due to the affinity of sertraline for the dopamine reuptake site. Because citalopram is the most specific SSRI showing this effect, it is concluded that the SSRI-induced decrement of vigilance performance is specifically associated with serotonergic reuptake inhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881105048887

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 24

  1. 10.1016/0024-3205(93)90194-8 · DOI · Paper page
  2. 10.1016/S0166-4328(05)80275-X · DOI
  3. 10.1002/(SICI)1099-1077(199703/04)12:2<119::AID-HUP847>3.0.CO;2-W · doi:10.1002/(sici)1099-1077(199703/04)12:2<119::aid-hup847>3.0.co;2-w
  4. 10.1016/0165-0327(90)90079-N · DOI
  5. 10.1177/0269881198012003031 · DOI · Paper page
  6. 10.1016/S0304-3940(97)00451-5 · DOI
  7. Jacobs B L, 1995, Psychopharmacology: The Fourth Generation of Progress, 461
  8. 10.1016/S0006-3223(99)00082-7 · DOI
  9. Lezak M D, 1995, Neuropsychological Assessment, 3rd edn
  10. 10.1080/17470214808416738 · DOI · Paper page
  11. 10.1037/0735-7044.111.3.646 · doi:10.1037/0735-7044.111.3.646 · Paper page
  12. McNair D M, 1992, Manual for the Profile of Mood States (Revised). Educational and Industrial Testing Service
  13. Mulder-Hajonides-van-der-Meulen W R E H, International European Sleep Conference
  14. Nicholson A N, 1990, Alcohol Drugs Driving, 5, 287
  15. 10.1097/00004714-199806000-00006 · DOI · Paper page
  16. 10.3758/BF03342823 · DOI · Paper page
  17. 10.1002/(SICI)1099-1077(1998110)13:2+<S87::AID-HUP53>3.0.CO;2-8 · DOI · Paper page
  18. 10.1002/(SICI)1099-1077(199910)14:7<499::AID-HUP136>3.0.CO;2-1 · DOI
  19. 10.1016/S0893-133X(01)00361-X · DOI
  20. 10.1016/S0301-0511(96)05222-2 · DOI · Paper page
  21. 10.1177/026988110101500304 · DOI
  22. 10.1177/026988110201600303 · DOI · Paper page
  23. 10.1055/s-2001-17606 · DOI · Paper page
  24. 10.1001/archpsyc.1965.01720310065008 · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J.
Venue
Journal of Psychopharmacology
Published
2005-01
Volume
19
Issue
1
Pages
12-20
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2162752407
Cited by
73
References
6
FWCI
1.92
Type
journal article
Language
en
Open access
green
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. https://app.cochat.ai/papers/10.1177/0269881105048887
The paper
Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J. (2005). Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105048887

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.